Advitech annouces the upcoming departure of its CFO

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

TSX VENTURE EXCHANGE: AVI

QUEBEC CITY, Jan. 22 /CNW Telbec/ - Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) today announces that Christian Labbé, Vice-President, Chief Financial Officer and Secretary of the Corporation, informed Advitech about its intention to leave the Corporation to pursue other opportunities. His departure will be effective on March 31, 2010 .

"We sincerely thank Christian for his professionalism and his contribution to the development and the growth of Advitech for the past years" said Michael Stangel , President and Chief Executive Officer of Advitech.

ABOUT ADVITECH INC.

Advitech, which includes its subsidiary Botaneco Specialty Ingredients since November 20, 2009 , is a health sciences and technology company developing, manufacturing and marketing proprietary natural ingredients and formulations for oral and topical applications that have been clinically proven to be safe and effective for improving skin health and well being. The Corporation's products are based on three technological platforms which are: i) a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, ii) XP-828L for immune mediated inflammatory disorders, and iii) IM for anti-aging and wound healing. Advitech produces Hydresia(TM), a natural plant derived specialty ingredient which offers immediate moisturization advantages, formulating cost savings and excellent product aesthetics in a variety of product applications, Dermylex(R) for the treatment of mild-to-moderate psoriasis, and Nudremyl(TM) which acts on skin reconstruction, cellular regeneration and skin structure. More information is available and can be accessed at www.advitech.com and www.botaneco.ca.

This press release contains forward-looking statements, which reflect the Corporation's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

%SEDAR: 00021006EF

For further information: Michael Stangel, President and Chief Executive Officer, Advitech Inc., [phone]